OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients
Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 897-906
Open Access | Times Cited: 98

Showing 26-50 of 98 citing articles:

Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
Huiting Liu, Sai Yang, Hua Xian, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 81-95
Open Access

Systemic Therapies for Pediatric Alopecia Areata
Luiza Kalil, DanTasia Welch, Candrice R. Heath, et al.
Pediatric Dermatology (2025) Vol. 42, Iss. S1, pp. 36-42
Closed Access

The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
Aditya K. Gupta, Mary A. Bamimore, Paradi Mirmirani, et al.
Journal of Cosmetic Dermatology (2025) Vol. 24, Iss. 4
Open Access

Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
Simon Holmes, Matthew Harries, A. E. Macbeth, et al.
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 325-331
Closed Access | Times Cited: 17

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real‐life retrospective study
Gianluca Tavoletti, Luca Valtellini, Maria A. Mattioli, et al.
International Journal of Dermatology (2024)
Closed Access | Times Cited: 3

Recent approaches of antibody therapeutics in androgenetic alopecia
Su-Eon Jin, Jino Kim, Jong‐Hyuk Sung
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
Karoline Strobl, Jörg Klufa, Regina Jin, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 12, pp. 3142-3168
Closed Access | Times Cited: 3

Exploring the shared genetic mechanisms of atopic dermatitis and alopecia areata via bioinformatics approaches
Qianqian Chen, Ting Yang, Jiayi Cheng, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access

A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
Jacqueline Kussini, Wolfgang Pfützner, Stefan Mühlenbein
International Journal of Dermatology (2025)
Closed Access

Recent Advances in Drug Development for Hair Loss
Jino Kim, Seung Yong Song, Jong‐Hyuk Sung
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3461-3461
Open Access

Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases
Н. Н. Потекаев, G. P. Tereshchenko, E. R. Gumennaia, et al.
Meditsinskiy sovet = Medical Council (2025), Iss. 2, pp. 143-152
Open Access

Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
Simonetta I. Gaumond, Isabella Kamholtz, Joaquín J. Jiménez
Biologics (2025) Vol. 5, Iss. 2, pp. 11-11
Open Access

Sexual Dysfunction in Alopecia Areata: A Systematic Review
Piotr Krajewski, Aleksandra Złotowska, Jacek C. Szepietowski, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2602-2602
Open Access

Innovations and Emerging Therapies in Atopic Dermatitis Part 1
Robyn Okereke, Eric L. Simpson
Current Treatment Options in Allergy (2025) Vol. 12, Iss. 1
Closed Access

The current state of knowledge of the immune ecosystem in alopecia areata
Samuel Connell, Ali Jabbari
Autoimmunity Reviews (2022) Vol. 21, Iss. 5, pp. 103061-103061
Open Access | Times Cited: 16

Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report
Yan Xin, Munire Tayier, Sin Tong Cheang, et al.
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 9

Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?
Teruki Dainichi, Masashi Iwata, Yo Kaku
The Journal of Dermatology (2023) Vol. 51, Iss. 2, pp. 196-209
Closed Access | Times Cited: 8

Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
Huijuan Fang, Fengchuan Zhang, Wenjun Lin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
Dea Metko, Shanti Mehta, Cathryn Sibbald
Pediatric Dermatology (2024) Vol. 41, Iss. 6, pp. 1123-1126
Open Access | Times Cited: 2

Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
W. Du, Ke He, Xin-Yi Liu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2

735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD
Dev Patel, Ben Hu, Omar Alani, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. Supplement_2
Closed Access | Times Cited: 2

Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata
Xiaojing Yang, Caiqing Zhang, Xuming Zhao, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 2, pp. 114259-114259
Closed Access | Times Cited: 2

Allergen desensitization reduces the severity of relapsed alopecia areata in dust‐mite allergic patients
Zixun Zeng, Shuifeng Li, Yanting Ye, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 7, pp. 1108-1119
Closed Access | Times Cited: 6

Scroll to top